Stay Informed About New Multiple Sclerosis Meds

Kesimpta and Zeposia will add to the growing list of meds to treat relapsing-remitting multiple sclerosis (MS).

Expect most of these patients to start treatment right reduce flares and slow progression.

We're used to seeing the traditional injectables (Avonex, Copaxone, etc) first-line...while some patients prefer an oral med (Aubagio, Gilenya, etc) or don't tolerate injectables.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote